Ulta Beauty, Inc. (NASDAQ:ULTA) appreciated by 3.15% at $204.62, after hitting low of $197.12 in an intra-day trade. Ulta Beauty, Inc. has 58.83 million shares outstanding, and in the last trade has seen ATR around 6.57. The volume of ULTA witnessed a shift from 2.7 million shares, based on a 50-day average, to 1.43 million shares.
In the most updated research from a number of analysts on Wall Street, the company gets 13 Buys and 0 Sell among 24 analysts. Ulta Beauty, Inc. (NASDAQ:ULTA) recently traded as high as $208.69. The consensus analyst target price is $273.1. That gives us a street projected return of 33.47%. If the published price targets set by Ulta Beauty, Inc. analysts have any power to influence the stock’s share price, the highest price target set for ULTA is $350.
Ulta Beauty, Inc. most recently reported earnings per share (EPS) of $1.83 for the July 2017 versus $1.43 in the same quarter last year, representing 28% growth. Analysts had predicted $1.78. Revenue during the quarter was $1.29 billion, representing 21% growth from $1.07 billion in year-ago quarter. The company’s quarterly EPS surprised Wall Street by as much as 3% to the upside in its last earnings announcement, so investors should note this tendency when assessing consensus estimates.
On a similar note, analysts expect EPS of $1.66 in October 2017 quarter and $2.82 in January 2018 quarter, representing 18.57% and 25.89% growth, respectively. They expect this year’s earnings to rise 28.22% year-over-year to $8.36, followed by 17.34% growth in the next year to $9.81.
Shares of Tenet Healthcare Corp. (NYSE:THC) traded up 2.93% in the last session while performance was up 13.35% in the last five days. The stock’s last price was lower from the average trading price of 50 days recorded at $15.55 while enlarging the period to 200 trading days, the average price was $17.44. Currently, 106.27 million total shares are owned by the public and among those 98.66 million shares have been available to trade. The percentage of shares being held by the company management was 0.7% while institutional stake was 0%.
Tenet Healthcare Corp. (THC) is recuperating from the fall at $12.25, the 52-week low. The stock has risen 8.98% since then. The trading saw a strength at $24.13 , the 52-week high. But since then, those gains have faded by -44.67%. THC has lost -14.26% in the 1-month period.
Ulta Beauty, Inc. has a beta of 1.18, offering the possibility of a higher rate of return, but also posing more risk. The portion of a company’s profit allocated to each outstanding share of common stock was -$1.96 a share in the trailing twelve months. It last reported revenues of $4.8 billion and EPS of -$0.17 for the June 2017, representing -1% top-line growth and 0.38 EPS growth.
Looking forward, the company’s quarterly earnings are expected to come at -$0.35 in the three months through September 2017 and $1.63 in the quarter ending December 2017, reflecting -318.75% and 2616.67% growth, respectively. For the full year, analysts expect earnings to decline -21.15% yoy to $0.82. Next year this growth will reach 54.88% to attain $1.27.